Global Cell-Based Assays Market Size, Share, Growth Analysis, By Products & Services(Reagents, Assay Kits), By Application(Basic Research, Drug Discovery), By End-Use(Pharmaceutical and Biotechnology Companies, Academic & Research Institutes) - Industry Forecast 2024-2031

Report ID: SQMIG35H2154 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 100 | Figures: 66

Global Cell-Based Assays Market News

In August 2022, Life Net Health LifeSciences introduced the Cell-Based Assay Services.

In May 2022, The Aquios STEM system was introduced by Beckman Coulter Life Sciences to offer a fresh approach to stem cell analysis.

Global Cell-Based Assays Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cell-Based Assays Market size was valued at USD 17.6 billion in 2022 and is poised to grow from USD 19.14 billion in 2023 to USD 37.44 billion by 2031, growing at a CAGR of 8.75% during the forecast period (2024-2031).

The competitive landscape of the global cell-based assays market is marked by intense innovation, strategic collaborations, and a focus on cutting-edge technology to meet the expanding demands of drug discovery, toxicology studies, and biomedical research. Industry leaders like Thermo Fisher Scientific, Merck KGaA, and PerkinElmer have established their dominance through a combination of advanced assay development, extensive product portfolios, and global reach. 'Thermo Fisher Scientific, Inc. (United States)', 'Promega Corporation (United States)', 'Merck KGaA (Germany)', 'PerkinElmer, Inc. (United States)', 'Danaher Corporation (United States)', 'Cell Signaling Technology, Inc. (United States)', 'Bio-Rad Laboratories, Inc. (United States)', 'Agilent Technologies, Inc. (United States)', 'GE Healthcare (United Kingdom)', 'Lonza Group Ltd. (Switzerland)'

The increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurodegenerative disorders fuels the demand for advanced cell-based assays for disease modeling and drug testing.

3D Cell Culture Advancements: The shift towards more physiologically relevant 3D cell culture models is gaining traction, allowing better recapitulation of in vivo conditions and enabling improved drug screening and toxicity assessment.

North America stands as the dominant force globally, commanding a substantial market share, and this is attributed to its well-established healthcare sector and the widespread adoption of cell-based assays. The United States, in particular, showcases a robust healthcare landscape and a remarkable proclivity towards utilizing cell-based assays. Notably, the escalating prevalence of chronic diseases such as cancer, osteoarthritis, and diabetes within the United States fuels an augmented demand for cell-based assays, especially in the realm of pioneering drug discoveries. This phenomenon significantly contributes to the market's expansion, acting as a pivotal growth catalyst.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Cell-Based Assays Market Size, Share, Growth Analysis, By Products & Services(Reagents, Assay Kits), By Application(Basic Research, Drug Discovery), By End-Use(Pharmaceutical and Biotechnology Companies, Academic & Research Institutes) - Industry Forecast 2024-2031

Global Cell-Based Assays Market News

Global Cell-Based Assays Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Cell-Based Assays Market?

Who are the key vendors in the Global Cell-Based Assays Market?

What is the key driver of Global Cell-Based Assays Market?

What is the key market trend for Global Cell-Based Assays Market?

Which region accounted for the largest share in Global Cell-Based Assays Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300